TNYA Stock Summary and Trading Ideas (Tenaya Therapeutics | NASDAQ:TNYA)

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Tenaya Therapeutics trades on the NASDAQ stock market under the symbol TNYA.

As of March 9, 2026, TNYA stock price climbed to $0.93 with 2,594,947 million shares trading.

TNYA has a beta of 2.29, meaning it tends to be more sensitive to market movements. TNYA has a correlation of 0.06 to the broad based SPY ETF.

TNYA has a market cap of $201.35 million. This is considered a Small Cap stock.

In the last 3 years, TNYA traded as high as $8.09 and as low as $.36.

The top ETF exchange traded funds that TNYA belongs to (by Net Assets): VTI, IBB, VXF, IBBQ, BIB.

TNYA has outperformed the market in the last year with a price return of +97.9% while the SPY ETF gained +17.2%. However, in the short term, TNYA had mixed performance relative to the market. It has underperformed in the last 3 months, returning -34.0% vs -2.9% return in SPY. But in the last 2 weeks, TNYA shares have fared better than the market returning +50.2% compared to SPY -3.7%.

TNYA support price is $.82 and resistance is $.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNYA shares will trade within this expected range on the day.